Articles from Business Wire (December 10, 2006)

Title	Author	Type	Words
ARIAD Presents Preclinical Efficacy Data on AP24534, a Novel Oral Kinase Inhibitor for Drug-Resistant CML.			982
Bioenvision Announces Latest Data on Evoltra(R) in Pediatric and Adult Leukemias.			1153
ChemGenex Investigators Report Activity of Ceflatonin(R) and Gleevec(R) Combination Therapy in CML Patients Resistant to Gleevec(R) Alone.			1123
Final Phase 2 Data Continue to Show Promising Results after One Year of Aranesp(R) Treatment for Anemia in Patients with Myelodysplastic Syndromes (MDS).		Disease/Disorder overview	1885
Osiris Therapeutics Provides Update on Phase II Trial Evaluating PROCHYMAL(TM) for the Treatment of Acute Graft vs. Host Disease.			1633
PANAMERSA Corporation/PayPro, Inc. Message to Shareholders Concerning 4th Quarter Dividend.			645
Phase I/II Data Support Continued Development of Biogen Idec's Novel Anti-CD23 Antibody for Chronic Lymphocytic Leukemia.			888
President Clinton, Ted Koppel, Shimon Peres and Haim Saban at the 2006 Saban Forum in Washington, D.C.			366
Taco Bell(R) Assures Public That Its Restaurants Are Safe.			613
What Does Winning $80,000 Mean? Spoil the Grandchildren!			405